169 related articles for article (PubMed ID: 22903682)
1. EVER2 deficiency is associated with mild T-cell abnormalities.
Crequer A; Picard C; Pedergnana V; Lim A; Zhang SY; Abel L; Majewski S; Casanova JL; Jablonska S; Orth G; Jouanguy E
J Clin Immunol; 2013 Jan; 33(1):14-21. PubMed ID: 22903682
[TBL] [Abstract][Full Text] [Related]
2. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
[TBL] [Abstract][Full Text] [Related]
3. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
[TBL] [Abstract][Full Text] [Related]
4. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
5. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
6. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
8. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
10. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
11. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
Zuo YG; Ma D; Zhang Y; Qiao J; Wang B
J Dermatol Sci; 2006 Dec; 44(3):153-9. PubMed ID: 17008061
[TBL] [Abstract][Full Text] [Related]
13. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.
Lazarczyk M; Dalard C; Hayder M; Dupre L; Pignolet B; Majewski S; Vuillier F; Favre M; Liblau RS
PLoS One; 2012; 7(6):e39995. PubMed ID: 22761942
[TBL] [Abstract][Full Text] [Related]
14. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.
Li SL; Duo LN; Wang HJ; Dai W; Zhou EH; Xu YN; Zhao T; Xiao YY; Xia L; Yang ZH; Zheng LT; Hu YY; Lin ZM; Wang HN; Gao TW; Ma CL; Yang Y; Li CY
Br J Dermatol; 2016 Dec; 175(6):1204-1209. PubMed ID: 27087313
[TBL] [Abstract][Full Text] [Related]
15. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
[TBL] [Abstract][Full Text] [Related]
16. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
[TBL] [Abstract][Full Text] [Related]
17. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
[TBL] [Abstract][Full Text] [Related]
18. The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.
Kalińska-Bienias A; Kowalewski C; Majewski S
Postepy Dermatol Alergol; 2016 Apr; 33(2):75-80. PubMed ID: 27279814
[TBL] [Abstract][Full Text] [Related]
19. Epidermodysplasia verruciformis: report of two patients with autosomal dominant inheritance.
Miotto IZ; De Oliveira WRP
Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818984
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.
Lazarczyk M; Pons C; Mendoza JA; Cassonnet P; Jacob Y; Favre M
J Exp Med; 2008 Jan; 205(1):35-42. PubMed ID: 18158319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
